Whole Genome Amplification

Whole genome amplification (WGA) uniformly increases the amount of DNA in the entire genome, enabling detailed study of samples that would otherwise be too small to analyze fully. This webinar will focus on strategies for performing successful WGA. Different methodologies for WGA will be presented, including Multiple Displacement Amplification (MDA) and PCR-based amplification. The importance of sample quality and sample storage on downstream analyses, along with performance data for QIAGEN’s REPLI-g technology, which provides highly uniform DNA amplification across the entire genome with negligible sequence bias, will also be discussed.

Whole genome amplification (WGA) uniformly increases the amount of DNA in the entire genome, enabling detailed study of samples that would otherwise be too small to analyze fully. This webinar will focus on strategies for performing successful WGA. Different methodologies for WGA will be presented, including Multiple Displacement Amplification (MDA) and PCR-based amplification. The importance of sample quality and sample storage on downstream analyses, along with performance data for QIAGEN’s REPLI-g technology, which provides highly uniform DNA amplification across the entire genome with negligible sequence bias, will also be discussed.

Hide details

Dr. Inga Irle

Dr. Irle obtained her Master of Science degree in Biochemistry from the Ruhr University in Bochum, Germany, focusing on molecular medicine and biomarker discovery. She received her PhD in 2009 at the University of Duisburg-Essen, where she worked in the field of cancer and epigenetics. Dr. Irle joined QIAGEN in 2010 and was responsible for Whole Genome Amplification products. She is currently Global Product Manager for QIAGEN's qPCR product portfolio.

Dr. Irle obtained her Master of Science degree in Biochemistry from the Ruhr University in Bochum, Germany, focusing on molecular medicine and biomarker discovery. She received her PhD in 2009 at the University of Duisburg-Essen, where she worked in the field of cancer and epigenetics. Dr. Irle joined QIAGEN in 2010 and was responsible for Whole Genome Amplification products. She is currently Global Product Manager for QIAGEN's qPCR product portfolio.